Neuronal Populations	1
Regeneration	33
a Combined Treatment	56
Rats with Spinal Cord Transection ROMANA VAVREK ,1 DAMIEN D. PEARSE ,2	80
Rats	80
Spinal Cord Transection ROMANA VAVREK ,1 DAMIEN D. PEARSE ,2	90
KARIM FOUAD1 ABSTRACT Axonal regeneration	154
KARIM FOUAD1	154
ABSTRACT Axonal regeneration	168
spinal cord injury -LRB- SCI -RRB- in adult mammals	203
spinal cord injury -LRB- SCI -RRB-	203
spinal cord injury	203
SCI	223
adult mammals	231
inhibitors associated with myelin and the glial scar	259
inhibitors	259
myelin and the glial scar	286
myelin	286
the glial scar	297
these inhibitors	325
a combined approach	343
We	381
complete SCI	429
rats , a combination of bridging the lesion with Schwann cell -LRB- SC -RRB- --	445
rats	445
a combination of bridging the lesion with Schwann cell -LRB- SC -RRB-	451
a combination	451
the lesion	477
Schwann cell -LRB- SC -RRB-	493
Schwann cell	493
SC	507
guidance channels , olfactory ensheathing glia implantation , and chondroitinase	518
guidance channels	518
olfactory ensheathing glia implantation	537
chondroitinase	582
ABC delivery	597
regeneration of serotonergic fibers	619
regeneration	619
serotonergic fibers	635
the lumbar spinal cord	660
addition	687
this combinatory treatment	697
locomotor recovery	747
these findings	781
we	797
this combined treatment	809
fibers other than serotonergic axons	851
fibers	851
serotonergic axons	869
the caudal spinal cord	917
this experiment	944
we	961
the retrograde tracer FluoroGold -LRB- FG -RRB-	973
the retrograde tracer FluoroGold	973
FG	1007
the spinal cord caudal	1016
a complete transection in a control and a treated group	1042
a complete transection	1042
a control and a treated group	1068
a control	1068
a treated group	1082
FG-positive cells rostral	1099
the lesion	1128
the brainstem of animals in the treated group	1146
the brainstem	1146
animals in the treated group	1163
animals	1163
the treated group	1174
axons	1204
the SC bridge	1241
the caudal spinal cord	1264
rats	1296
cells	1313
the reticulospinal nuclei , vestibular nuclei , and the raphe nucleus	1322
the reticulospinal nuclei	1322
vestibular nuclei	1349
the raphe nucleus	1372
the spinal cord	1404
Cell numbers	1421
highest in the thoracic spinal cord and the lateral vestibular nucleus	1439
highest	1439
the thoracic spinal cord and the lateral vestibular nucleus	1450
the thoracic spinal cord	1450
the lateral vestibular nucleus	1479
the mechanisms	1523
the superior capability of these cell populations	1542
the superior capability	1542
these cell populations	1569
valuable clues	1618
the design of future treatment approaches	1636
the design	1636
future treatment approaches	1650
INTRODUCTION AXONS OF THE MAMMALIAN CENTRAL NERVOUS SYSTEM -LRB- CNS -RRB-	1680
INTRODUCTION AXONS OF THE MAMMALIAN CENTRAL NERVOUS SYSTEM	1680
INTRODUCTION AXONS	1680
THE MAMMALIAN CENTRAL NERVOUS SYSTEM	1702
CNS	1740
following injury	1770
This lack of regeneration	1788
This lack	1788
regeneration	1801
a combination of factors	1833
a combination	1833
factors	1850
the inhibitory character	1869
the astrocytic scar	1897
the lesion site	1931
myelin-associated inhibitors	1948
insufficient neurotrophic support	1982
Schwab and Bartholdi	2017
1996	2039
the inhibitory environment of the injured spinal cord	2058
the inhibitory environment	2058
the injured spinal cord	2088
a growth	2127
permissive bridge for regenerating axons	2136
permissive bridge	2136
regenerating axons	2158
we	2178
a combinatory therapy of a Schwann cell -LRB- SC -RRB-	2200
a combinatory therapy	2200
a Schwann cell	2225
SC	2241
guidance channel , injections of olfactory-ensheathing glia -LRB- OEG -RRB-	2256
guidance channel	2256
injections of olfactory-ensheathing glia -LRB- OEG -RRB-	2274
injections	2274
olfactory-ensheathing glia -LRB- OEG -RRB-	2288
olfactory-ensheathing glia	2288
OEG	2316
the rostral and caudal stumps of the host spinal cord	2326
the rostral	2326
caudal stumps of the host spinal cord	2342
caudal stumps	2342
the host spinal cord	2359
intrathecal delivery of chondroitinase	2385
intrathecal delivery	2385
chondroitinase	2409
ABC -LRB- cABC -RRB-	2424
ABC	2424
cABC	2429
the bridge/stump interfaces -LRB- Fouad et al. , 2005 -RRB-	2438
the bridge/stump interfaces	2438
Fouad	2467
et al. , 2005	2473
et al.	2473
2005	2481
This combined therapy	2488
significantly improved hind limb function	2522
significantly improved hind limb	2522
function	2555
the numbers of myelinated axons	2575
the numbers	2575
myelinated axons	2590
the SC bridges	2614
regeneration of serotonergic fibers	2643
regeneration	2643
serotonergic fibers	2659
the lumbar spinal cord	2684
the lack of correlation between recovery and regenerated serotonergic fibers	2717
the lack	2717
correlation	2729
recovery	2749
serotonergic fibers	2774
other fiber types	2814
regeneration	2848
a shortcoming of the study	2868
a shortcoming	2868
the study	2885
Fouad	2898
et al. -LRB- 2005 -RRB-	2904
et al.	2904
2005	2912
the use of an anterograde tracer	2922
the use	2922
an anterograde tracer	2933
the motor cortex only , which failed to provide evidence for that possibility	2960
the motor cortex only	2960
evidence	3007
that possibility	3020
The goal of the current study	3038
The goal	3038
the current study	3050
the combined treatment	3092
neuronal populations	3128
the tissue bridge	3175
the caudal spinal cord	3202
a retrograde tracer caudal	3239
the injury	3269
METHODS All procedures were performed according to Fouad	3282
METHODS	3282
All procedures	3290
Fouad	3333
et al.	3339
2005	3347
adult female Fischer rats -LRB- Charles River , Wilmington , MA -RRB-	3360
adult female Fischer rats	3360
Charles River	3387
Wilmington	3402
MA	3414
The experiment	3419
local authorities	3450
SC and OEGs	3469
Fouad et al. , 2005	3520
Fouad	3520
et al.	3526
2005	3534
SCs	3551
sciatic nerves of adult female Fischer rats	3574
sciatic nerves	3574
adult female Fischer rats	3592
cultures of OEG	3655
cultures	3655
OEG	3667
the nerve fiber layer of the olfactory bulb of adult female Fischer rats	3690
the nerve fiber layer	3690
the olfactory bulb of adult female Fischer rats	3715
the olfactory bulb	3715
adult female Fischer rats	3737
a procedure modified from one described previously	3769
a procedure	3769
one described previously	3795
one	3795
Ramón-Cueto	3821
et al. , 1998	3833
et al.	3833
1998	3841
SCs or OEG	3857
DMEM/F -12 medium	3886
transplantation	3911
OEG	3928
them	3959
the dishes	3969
the cells	3985
a hemocytometer	4014
SCs	4031
a 60:40 -LRB- v/v -RRB- solution	4055
DMEM/F -12 / Matrigel -LRB- BD Biosciences , San Jose , CA -RRB-	4081
DMEM/F -12 / Matrigel	4081
DMEM/F -12	4081
Matrigel	4091
BD Biosciences	4101
San Jose	4117
CA	4127
Each animal	4160
a total of 5 x 10 ^ 6 SCs	4181
a total of 5	4181
a total	4181
5	4192
10 ^ 6 SCs	4196
10	4196
6 SCs	4199
transplantation	4209
OEG	4226
aliquots of 4 µL of DMEM/F -12 medium	4250
aliquots	4250
4 µL of DMEM/F -12 medium	4262
4 µL	4262
DMEM/F -12 medium	4270
4 x 10 ⌃	4298
4 x 10	4298
4	4298
10	4302
5 cells	4305
spinal cord injection	4332
the surgery	4359
animals	4372
Hypnorm	4403
120 µL per 200 g bw ; Janssen Pharmaceutics , Beerse , Belgium	4412
120 µL	4412
200 g bw ; Janssen Pharmaceutics , Beerse , Belgium	4423
200 g bw	4423
Janssen Pharmaceutics , Beerse , Belgium	4433
Janssen Pharmaceutics	4433
Beerse , Belgium	4456
Midazolam	4477
0.75 mg	4488
150 µL/200 g bwt ; s.c. ; 750 µL total volume	4499
150 µL/200 g bwt	4499
s.c. ; 750 µL total volume	4517
s.c.	4517
750 µL total volume	4523
750 µL	4523
total volume	4530
H2O ; Sabex , Boucherville , Quebec , Canada	4554
H2O	4554
Sabex , Boucherville , Quebec , Canada	4559
a laminectomy of the thoracic 7 -- 9 vertebral segment	4603
a laminectomy of the thoracic 7	4603
a laminectomy	4603
the thoracic 7	4620
9 vertebral segment	4635
a 4-mm region of spinal cord encompassing Th8	4656
a 4-mm region	4656
spinal cord encompassing Th8	4673
spinal cord	4673
Th8	4698
the treated group	4718
a volume of 1 µL containing ≈ 105 OEG in DMEM/F -12	4737
a volume	4737
1 µL containing ≈ 105 OEG in DMEM/F -12	4749
1 µL	4749
≈ 105 OEG	4765
DMEM/F -12	4777
each stump	4804
the spinal cord stumps	4822
2 mm	4859
60:40 polyacrylonitrile	4902
polyvinylchloride copolymer	4927
2.6-mm inner diameter	4973
3.0-mm outer diameter	4996
provided by T. Hazlett , CytoTherapeutics , Providence , RI	5019
T. Hazlett , CytoTherapeutics , Providence ,	5031
Thirty microliters	5078
SC suspended in a 60:40 -LRB- v/v -RRB- solution of DMEM/F -12 in Matrigel	5100
SC	5100
a 60:40 -LRB- v/v -RRB- solution of DMEM/F -12	5116
a 60:40 -LRB- v/v -RRB- solution	5116
DMEM/F -12	5142
Matrigel	5155
the channel	5182
windows	5202
Chondroitinase ABC -LRB- cABC ; Seikagaku America , East Falmouth , MA -RRB-	5211
Chondroitinase ABC	5211
cABC ; Seikagaku America	5231
cABC	5231
Seikagaku America	5237
East Falmouth , MA	5256
East Falmouth	5256
MA	5271
the SC bridge/host	5295
spinal cord interfaces	5314
osmotic mini-pumps -LRB- model 2002 ; Alzet , Cupertino , CA -RRB-	5343
osmotic mini-pumps	5343
model 2002 ; Alzet , Cupertino , CA	5363
model 2002	5363
Alzet , Cupertino , CA	5375
The pumps , connected to two catheters ,	5398
The pumps	5398
two catheters	5422
sterile 0.9 % NaCl	5447
the catheters	5473
the intervals between cABC injections	5500
the intervals	5500
cABC injections	5522
2 µL of 10 µg/mL cABC	5539
2 µL	5539
10 µg/mL cABC	5547
Injections of cABC into the catheters	5563
Injections	5563
cABC into the catheters	5577
cABC	5577
the catheters	5587
every other day for 4 weeks	5616
every other day	5616
4 weeks	5636
the catheter	5661
the pump under isoflurane anesthesia	5679
the pump	5679
isoflurane anesthesia	5694
The control group	5717
a transection	5744
Retrograde tracing	5764
Retrograde	5764
10 weeks postsurgery in treated and untreated rats	5797
10 weeks	5797
treated and untreated rats	5821
the tracing procedure	5853
a bilateral injection	5876
1 µL of 5 % FlouroGold -LRB- Chemicon International , Inc. , Temecula , CA -RRB-	5901
1 µL	5901
5 % FlouroGold -LRB- Chemicon International , Inc. , Temecula , CA -RRB-	5909
5 % FlouroGold	5909
Chemicon International	5924
Inc.	5948
Temecula , CA	5954
the Th13 segment of the spinal cord	5987
the Th13 segment	5987
the spinal cord	6007
A glass microelectrode with a tip diameter of 20 -- 30 µm	6024
A glass microelectrode	6024
a tip diameter of 20 -- 30 µm	6052
a tip diameter of 20	6052
a tip diameter	6052
20	6070
30 µm	6073
a Hamilton syringe	6096
the exposed spinal cord	6132
250 µm lateral to the midline and to a depth of ≈ 400 µm	6162
250 µm lateral	6162
the midline	6180
a depth of ≈ 400 µm	6199
a depth	6199
≈ 400 µm	6210
The electrode	6219
place	6245
1 min following injection	6255
1 min	6255
injection	6271
Two weeks later	6282
the animals	6299
pentobarbital -LRB- Euthanyl , Bimeda-MTC ; 70 mg/100 mg body weight -RRB-	6332
pentobarbital	6332
Euthanyl , Bimeda-MTC ; 70 mg/100 mg body weight	6347
Euthanyl , Bimeda-MTC	6347
70 mg/100 mg body weight	6369
70 mg/100	6369
mg body weight	6379
a cryostat	6415
horizontal sections of the spinal cord and cross-sections of the brains	6427
horizontal sections	6427
the spinal cord and cross-sections of the brains	6450
the spinal cord	6450
cross-sections of the brains	6470
cross-sections	6470
the brains	6488
25 m	6517
The extent of the FG spreading	6524
The extent	6524
the FG spreading	6538
fluorescence microscopy	6574
neurons that did not regenerate into the caudal spinal cord	6619
neurons	6619
the caudal spinal cord	6656
animals where FG was detected closer than 2.5 mm caudal to the bridge	6680
animals	6680
FG	6694
closer than 2.5 mm caudal	6710
the bridge	6739
further analyzed	6759
further	6759
This	6777
a final group size of five animals in the combined treatment and four	6794
a final group size	6794
five animals in the combined treatment and four	6816
five animals	6816
the combined treatment and four	6832
the combined treatment	6832
four	6859
the control group	6867
an approach to explain the variability in our results	6889
the variability in our results	6912
the variability	6912
our results	6931
we	6944
the cross-section area of the tissue bridge at its narrowest point	6956
the cross-section area	6956
the tissue bridge at its narrowest point	6982
the tissue bridge	6982
its narrowest point	7003
light microscopy	7032
we	7061
the extent of the tissue on all the horizontal sections	7073
the extent	7073
the tissue on all the horizontal sections	7087
the tissue	7087
all the horizontal sections	7101
the bridge	7137
the average of these numbers	7163
the average	7163
these numbers	7178
the dorsal ventral extent	7195
the bridge -LRB- i.e. , number of section x 25 µm -RRB-	7224
the bridge	7224
section x 25 µm	7252
section	7252
25 µm	7262
An additional approach to explain the variability	7270
the variability	7304
variations	7334
the cABC-digested proteoglycans between the animals	7348
the cABC-digested proteoglycans	7348
the animals	7388
Fouad et al. -LRB- 2005 -RRB- and Moon et al. -LRB- 2001 -RRB-	7415
Fouad et al. -LRB- 2005 -RRB-	7415
Fouad	7415
et al. -LRB- 2005 -RRB-	7421
et al.	7421
2005	7429
Moon et al. -LRB- 2001 -RRB-	7439
Moon	7439
et al. -LRB- 2001 -RRB-	7444
et al.	7444
2001	7452
horizontal -LRB- 25 µm -RRB- sections	7470
25 µm	7482
the thoracic spinal cord	7506
the lesion	7543
mouse	7579
anti-chondroitin-4-sulfate monoclonal antibody	7585
C4S , 1:100 ; Chemicon International	7633
C4S	7633
1:100 ; Chemicon International	7638
1:100	7638
Chemicon International	7645
48 h	7673
secondary detection	7690
DAB vector kit -LRB- Vector Labs , Burlingame , CA -RRB-	7730
DAB vector kit	7730
Vector Labs	7746
Burlingame	7759
CA	7771
Staining -LRB- antibody exposure and visualization -RRB- of all slides	7776
Staining -LRB- antibody exposure and visualization -RRB-	7776
Staining	7776
antibody exposure and visualization	7786
antibody exposure	7786
visualization	7808
all slides	7826
Digital images	7867
200 µm	7903
the spinal cord rostral and caudal	7915
the spinal cord rostral	7915
caudal	7943
the bridge at 10x magnification	7953
the bridge	7953
10x magnification	7967
Images	7986
density	8011
Scion Image software -LRB- NIH -RRB-	8025
Scion Image software	8025
NIH	8047
results	8057
an average density measure -LRB- 2 images/rat -RRB-	8083
an average density measure	8083
2 images/rat	8111
The immuno-staining procedure against FG	8126
The immuno-staining procedure	8126
FG	8164
anti	8192
FG antibody -LRB- 1:1000 ; Chemicon International -RRB-	8197
FG antibody	8197
1:1000 ; Chemicon International	8210
1:1000	8210
Chemicon International	8218
a 10 % normal goat serum -LRB- NGS -RRB-	8249
a 10 % normal goat serum	8249
NGS	8274
step	8288
secondary antibody -LRB- Vector -RRB-	8307
secondary antibody	8307
Vector	8327
the instructions of the manufacturer	8348
the instructions	8348
the manufacturer	8368
the Nova Red kit -LRB- Vector -RRB-	8406
the Nova Red kit	8406
Vector	8424
cell bodies , consecutive cross-sections	8463
the brain and brainstem and horizontal sections	8511
the brain and brainstem	8511
horizontal sections	8539
the spinal cord	8567
light microscopy	8603
The location and number of Nova Red -- positive neurons	8621
The location and number	8621
Nova Red -- positive neurons	8648
Nova Red	8648
positive neurons	8657
each section	8695
an overlaid grid and a stereotaxic atlas -LRB- Paxinos and Watson , 1986 -RRB-	8713
an	8713
grid and a stereotaxic atlas -LRB- Paxinos and Watson , 1986 -RRB-	8725
grid	8725
a stereotaxic atlas -LRB- Paxinos and Watson , 1986 -RRB-	8734
a stereotaxic atlas	8734
Paxinos and Watson , 1986	8755
Paxinos	8755
Watson , 1986	8767
Watson	8767
1986	8775
RESULTS	8783
1	8797
NUMBER AND LOCATION OF RETROGRADELY	8800
NUMBER AND LOCATION	8800
NUMBER	8800
LOCATION	8811
RETROGRADELY	8823
CELLS	8844
THE INDIVIDUAL ANIMALS FIG. 1	8853
THE INDIVIDUAL ANIMALS FIG.	8853
1	8882
FlouroGold-positive neurons in the spinal cord in an overview -LRB- A -RRB- .	8885
FlouroGold-positive neurons	8885
the spinal cord	8916
an overview -LRB- A -RRB-	8935
an overview	8935
A	8948
cells	8973
intermediate laminae of the thoracic spinal cord , rostral	9004
intermediate laminae	9004
the thoracic spinal cord , rostral	9028
the thoracic spinal cord	9028
rostral	9054
the lesion site	9065
higher magnification	9088
these cells	9110
the thoracic and the cervical spinal cord	9151
the thoracic	9151
the cervical spinal cord	9168
No cells	9194
the untreated animals	9217
lines	9247
graywhite matter interface	9262
FlouroGold-positive neurons in the brainstem	9290
FlouroGold-positive neurons	9290
the brainstem	9321
various nuclei	9349
the schematic in B -LRB- modified from Paxinos and Watson , 1986 -RRB-	9380
the schematic in B	9380
Paxinos and Watson , 1986	9414
Paxinos and Watson	9414
1986	9434
Examples	9441
labeled cells in various nuclei	9453
labeled cells	9453
various nuclei	9470
paragigantocellular -LRB- LPGi -RRB- , rostroventrolateral reticular	9495
paragigantocellular -LRB- LPGi -RRB-	9495
RVL	9554
raphe pallidus -LRB- RPa -RRB-	9560
raphe pallidus	9560
RPa	9576
lateral vestibular nucleus -LRB- LVe -RRB-	9586
lateral vestibular nucleus	9586
LVe	9614
C	9632
The remaining abbreviations of brainstem nuclei	9635
The remaining abbreviations	9635
brainstem nuclei	9666
the result section	9699
the animals that received the combination treatment	9723
the animals	9723
the combination treatment	9749
we	9776
cell bodies	9806
the spinal cord rostral	9821
the lesion bridge/site	9848
the brainstem	9878
the highest number	9898
labeled cell bodies	9920
the thoracic spinal cord in laminae VII and VIII -LRB- Fig. 1A -RRB-	9943
the thoracic spinal cord in laminae VII	9943
the thoracic spinal cord	9943
laminae VII	9971
VIII -LRB- Fig. 1A -RRB-	9987
VIII	9987
Fig. 1A	9993
The cell bodies	10003
the central canal	10037
locations	10070
interneurons	10094
the lumbar spinal cord -LRB- Vavrek et al. , 2006 -RRB-	10121
the lumbar spinal cord	10121
Vavrek	10145
et al. , 2006	10152
et al.	10152
2006	10160
cell bodies	10175
size	10206
clusters	10227
These findings	10237
sharp contrast	10261
those in the transection-only group	10279
those	10279
the transection-only group	10288
no retrogradely labeled cell bodies	10322
no retrogradely	10322
cell bodies	10346
the treated group	10373
the numbers of the regenerated propriospinal interneurons	10392
the numbers	10392
the regenerated propriospinal interneurons	10407
PrI	10451
the rostral spinal cord	10459
increasing distance from the lesion site	10512
increasing distance	10512
the lesion site	10537
a rostral-caudal distance of 2 cm	10572
a rostral-caudal distance	10572
2 cm	10601
the mean number of the labeled PrI in the thoracic spinal cord in treated rats	10607
the mean number	10607
the labeled PrI in the thoracic spinal cord in treated rats	10626
the labeled PrI	10626
the thoracic spinal cord in treated rats	10645
the thoracic spinal cord	10645
treated rats	10673
238 ± 123 -LRB- mean ± SEM -RRB- and 12 ± 3.6 in the cervical spinal cord	10690
238 ± 123 -LRB- mean ± SEM -RRB-	10690
238	10690
± 123	10694
SEM	10708
12 ± 3.6 in the cervical spinal cord	10717
12 ±	10717
3.6 in the cervical spinal cord	10722
3.6	10722
the cervical spinal cord	10729
FG-positive neurons	10755
the brainstem	10794
the animals that received the combined treatment -LRB- Fig. 1B , C -RRB-	10811
the animals	10811
the combined treatment	10837
Fig. 1B , C	10861
Fig. 1B	10861
C	10869
These results	10873
Table 1	10905
all animals	10931
the majority of labeled neurons in the brainstem	10944
the majority	10944
labeled neurons in the brainstem	10960
labeled neurons	10960
the brainstem	10979
the vestibular nuclei	11006
70 %	11035
the lateral vestibular nucleus -LRB- LVe -RRB-	11051
the lateral vestibular nucleus	11051
LVe	11083
median vestibular nucleus -LRB- MVe -RRB-	11089
median vestibular nucleus	11089
MVe	11116
superior vestibular nucleus -LRB- SuVe -RRB-	11122
superior vestibular nucleus	11122
SuVe	11151
spinal vestibular nucleus -LRB- SpVe -RRB-	11162
spinal vestibular nucleus	11162
SpVe	11189
18 % of all labeled	11202
18 %	11202
all labeled	11209
all	11209
neurons in the brainstem	11221
neurons	11221
the brainstem	11232
the reticular formation	11264
12 % in raphe nuclei	11298
12 %	11298
raphe nuclei	11305
No FG-positive cells	11319
the red nucleus and , in agreement	11360
the red nucleus	11360
agreement	11384
our earlier results -LRB- Fouad et al. , 2005 -RRB-	11399
our earlier results	11399
Fouad	11420
et al. , 2005	11426
et al.	11426
2005	11434
they	11450
the sensorimotor cortex	11464
FG-positive cells	11503
19 brainstem nuclei	11538
the LVe	11569
MVe	11578
SuVe	11583
SpVe	11589
noradrenaline cells -LRB- A2A2 -RRB-	11595
noradrenaline cells	11595
A2A2	11616
adrenaline cells -LRB- C2C2 -RRB-	11623
adrenaline cells	11623
C2C2	11641
parvocellular reticular nucleus -LRB- PCRt -RRB-	11648
parvocellular reticular nucleus	11648
PCRt	11681
gigantocellular reticular nucleus -LRB- Gi -RRB-	11688
gigantocellular reticular nucleus	11688
Gi	11723
gigantocellular reticular nucleus	11728
ventral part -LRB- GiV -RRB-	11763
ventral part	11763
GiV	11777
lateral paragigantocellular nucleus -LRB- LPGi -RRB-	11783
lateral paragigantocellular nucleus	11783
LPGi	11820
dorsal paragigantocellular nucleus -LRB- DPGi -RRB-	11827
dorsal paragigantocellular nucleus	11827
DPGi	11863
lateral reticular nucleus -LRB- LRt -RRB-	11870
lateral reticular nucleus	11870
LRt	11897
intermediate reticular nucleus -LRB- IRt -RRB-	11903
intermediate reticular nucleus	11903
IRt	11935
rostroventrolateral reticular nucleus -LRB- RVL -RRB-	11941
rostroventrolateral reticular nucleus	11941
RVL	11980
medullary reticular nucleus	11986
dorsal part -LRB- MdD -RRB-	12015
dorsal part	12015
MdD	12028
medullary reticular nucleus	12034
ventral part -LRB- MdV -RRB-	12063
ventral part	12063
MdV	12077
raphe pallidus nucleus -LRB- RPa -RRB-	12083
raphe pallidus nucleus	12083
RPa	12107
raphe obscurus nucleus -LRB- ROb -RRB-	12113
raphe obscurus nucleus	12113
ROb	12137
the raphe magnus nucleus -LRB- RMg -RRB-	12147
the raphe magnus nucleus	12147
RMg	12173
localization of retrogradely traced brainstem neurons	12192
localization	12192
retrogradely traced brainstem neurons	12208
Figure 1C	12265
possible causes	12291
differences in the number of regenerated axons between the treated rats	12311
differences	12311
the number of regenerated axons between the treated rats	12326
the number	12326
regenerated axons between the treated rats	12340
regenerated axons	12340
the treated rats	12366
the area of a cross-section at the narrowest point of the tissue bridge	12384
the area	12384
a cross-section at the narrowest point of the tissue bridge	12396
a cross-section	12396
the narrowest point of the tissue bridge	12415
the narrowest point	12415
the tissue bridge	12438
0.26	12472
0.22	12478
0.35	12484
0.16	12490
0.29 mm2 in rats 1 , 3 , 6 , 8 , and 9 , respectively	12500
0.29 mm2	12500
rats 1 , 3 , 6 , 8 , and 9 , respectively	12512
rats 1	12512
3	12520
6 , 8 , and 9	12523
These results	12551
the animal with the largest bridge diameter	12575
the animal	12575
the largest bridge diameter	12591
the largest number of regenerated cells	12634
the largest number	12634
regenerated cells	12656
these data -LRB- bridge diameter and number of regenerated axons -RRB-	12692
these data	12692
bridge diameter and number of regenerated axons	12704
bridge diameter and number	12704
regenerated axons	12734
a significant r value	12754
r = 0.83	12787
r	12787
= 0.83	12789
Another factor	12798
the observed variability in the number of regenerated axons	12834
the observed variability	12834
the number of regenerated axons	12862
the number	12862
regenerated axons	12876
the degree of cABC digestion	12897
the degree	12897
cABC digestion	12911
the degree of cABC digestion	12942
the degree	12942
cABC digestion	12956
the rostral and caudal stump	12974
the rostral	12974
caudal stump	12990
positive correlation	13004
the number of regenerated cells	13043
the number	13043
regenerated cells	13057
thoracic spinal cord and the total number of regenerated cells	13083
thoracic spinal cord	13083
the total number of regenerated cells	13108
the total number	13108
regenerated cells	13128
the amount of cABC digestion -LRB- r values of 0	13151
the amount	13151
cABC digestion -LRB- r values of 0	13165
cABC	13165
digestion -LRB- r values of 0	13170
digestion	13170
r values of 0	13181
r values	13181
0	13193
9 and 0.8 , respectively -RRB- .	13196
9 and 0.8 , respectively -RRB-	13196
9	13196
0.8 , respectively -RRB-	13202
0.8	13202
DISCUSSION	13223
The main conclusion of this study	13234
The main conclusion	13234
this study	13257
the combined treatment	13276
Fouad	13318
et al. , 2005	13324
et al.	13324
2005	13332
the regeneration	13345
neurons other than serotonergic fibers through a tissue bridge	13365
neurons	13365
serotonergic fibers through a tissue bridge	13384
serotonergic fibers	13384
a tissue bridge	13412
the spinal cord caudal to a complete lesion	13433
the spinal cord caudal	13433
a complete lesion	13459
Retrograde tracing , which was caudal to the lesion ,	13478
Retrograde tracing	13478
Retrograde	13478
the lesion	13518
spinal interneurons rostral	13538
the lesion and various populations of brainstem neurons	13569
the lesion	13569
various populations of brainstem neurons	13584
various populations	13584
brainstem neurons	13607
cells	13634
animals that received a spinal cord transection but no treatment	13655
animals	13655
a spinal cord transection but no treatment	13677
a spinal cord transection	13677
no treatment	13707
This	13721
labeling of cells	13740
labeling	13740
cells	13752
axons	13773
the bridge	13800
intravascular tracer spreading or its diffusion	13822
intravascular tracer spreading	13822
its diffusion	13856
the cerebrospinal fluid	13875
An important finding	13900
the consistency among treated animals	13924
the consistency	13924
treated animals	13946
other words	13966
the majority of retrogradely labeled neurons	13979
the majority	13979
retrogradely labeled neurons	13995
the rostral spinal cord and the vestibular nuclei	14044
the rostral spinal cord	14044
the vestibular nuclei	14072
the outstanding regenerative capabilities of these neurons	14109
the outstanding regenerative capabilities	14109
these neurons	14154
The superior regenerative capacity of interneurons	14169
The superior regenerative capacity	14169
interneurons	14207
other studies	14236
various treatment approaches	14256
Menei	14286
et al. , 1998 ; Tsai et al. , 2005	14292
et al.	14292
1998 ; Tsai et al.	14300
1998	14300
Tsai et al.	14306
Tsai	14306
et al.	14311
2005	14319
Our results	14326
the idea	14351
the cell body 's proximity to the lesion	14365
the cell body 's proximity	14365
the cell body 's	14365
the lesion	14394
its potential	14416
Xu et al. , 1999	14445
Xu	14445
et al.	14448
1999	14456
the number of retrogradely labeled interneuron cell bodies	14466
the number	14466
retrogradely labeled interneuron cell bodies	14480
retrogradely	14480
interneuron cell bodies	14501
increasing distance from the bridge/lesion site	14540
increasing distance	14540
the bridge/lesion site	14565
the ability of vestibular neurons to regenerate in response to various therapies	14594
the ability	14594
vestibular neurons	14609
response	14645
various therapies	14657
earlier studies -LRB- Menei et al. , 1998 ; Tsai et al. , 2005 -RRB-	14691
earlier studies	14691
Menei	14708
et al. , 1998 ; Tsai et al. , 2005	14714
et al.	14714
1998 ; Tsai et al.	14722
1998	14722
Tsai et al.	14728
Tsai	14728
et al.	14733
2005	14741
these neurons	14759
this capacity	14781
Future characterization	14819
the injury response	14846
the expression	14877
regeneration-associated genes or cAMP levels	14895
vestibular neurons after injury and treatment	14947
vestibular neurons	14947
injury and treatment	14972
important clues	15008
the promotion of regeneration in other axonal systems	15028
the promotion	15028
regeneration in other axonal systems	15045
regeneration	15045
other axonal systems	15061
the population of neurons able to regenerate	15092
the population	15092
neurons able to regenerate	15110
neurons	15110
animals	15167
there	15176
a significant deviation in the number of labeled cells	15186
a significant deviation	15186
the number of labeled cells	15213
the number	15213
labeled cells	15227
This	15242
the complex nature	15274
the combined treatment	15296
variability	15325
multiple factors	15354
differences in the inflammatory response	15382
differences	15382
the inflammatory response	15397
OEC implantation	15445
the stumps	15467
discrepancies of CSPG digestion	15480
discrepancies	15480
CSPG digestion	15497
the mechanical stability of the channels	15516
the mechanical stability	15516
the channels	15544
Measurements of the bridge diameters	15558
Measurements	15558
the bridge diameters	15574
the bridge size	15609
account for the variability	15641
account	15641
the variability	15653
the biggest area	15673
the rat	15703
the highest number of labeled cells	15716
the highest number	15716
labeled cells	15738
the bridge in the rat with the smallest number of cells	15762
the bridge	15762
the rat with the smallest number of cells	15776
the rat	15776
the smallest number of cells	15789
the smallest number	15789
cells	15812
that of the others , indicating that other factors are involved	15835
that	15835
the others	15843
other factors	15871
Another possible reason for more or less successful regeneration	15899
Another possible reason	15899
more or less successful regeneration	15927
the degree	15967
proteoglycan digestion	15981
the tissue penetration of the administered cABC	16022
the tissue penetration	16022
the administered cABC	16048
The finding	16071
the rat with the highest number of regenerated axons	16092
the rat	16092
the highest number of regenerated axons	16105
the highest number	16105
regenerated axons	16127
the digestion for proteoglycans	16146
the digestion	16146
proteoglycans	16164
this suggestion	16200
The results of the current study	16217
The results	16217
the current study	16232
a better understanding	16256
the mechanisms	16282
locomotor recovery following combined treatment	16310
locomotor recovery	16310
combined treatment	16339
Fouad	16359
et al. , 2005	16365
et al.	16365
2005	16373
the results	16389
serotonergic fibers	16414
the caudal stump of the spinal cord	16474
the caudal stump	16474
the spinal cord	16494
the spinal cord caudal	16533
the lesion	16559
These fibers	16571
great candidates for promoting locomotor recovery	16593
great candidates	16593
locomotor recovery	16624
serotonin	16647
lower thresholds for the initiation of locomotor activity	16682
lower thresholds	16682
the initiation of locomotor activity	16703
the initiation	16703
locomotor activity	16721
addition	16744
the grafting of serotonergic cells into the lumbar spinal cord on its own	16754
the grafting	16754
serotonergic cells into the lumbar spinal cord on its own	16770
serotonergic cells	16770
the lumbar spinal cord on its own	16794
the lumbar spinal cord	16794
its own	16820
locomotor recovery -LRB- Ribotta et al. , 2000 -RRB-	16854
locomotor recovery	16854
Ribotta	16874
et al. , 2000	16882
et al.	16882
2000	16890
the study by Fouad et al. -LRB- 2005 -RRB-	16909
the study	16909
Fouad et al. -LRB- 2005 -RRB-	16922
Fouad et al.	16922
Fouad	16922
et al.	16928
2005	16936
recovery	16943
the number of regenerated serotonergic fibers	16975
the number	16975
regenerated serotonergic fibers	16989
these axons	17044
a major contributor to the recovery	17059
a major contributor	17059
the recovery	17082
vestibulospinal fibers	17106
another group of fibers that showed superior regenerative capabilities	17133
another group	17133
fibers that showed superior regenerative capabilities	17150
fibers	17150
superior regenerative capabilities	17169
Neurons of the vestibulospinal tract	17205
Neurons	17205
the vestibulospinal tract	17216
locomotor activity	17273
extensor tone	17327
they	17351
the initiation of stepping movements -LRB- Mori et al. , 1992 -RRB-	17377
the initiation	17377
movements -LRB- Mori et al. , 1992 -RRB-	17404
movements	17404
Mori	17415
et al. , 1992	17420
et al.	17420
1992	17428
the major tract responsible for initiating stepping in rodents and cats	17444
the major tract	17444
rodents and cats	17499
the reticulospinal tract -LRB- Jordan , 1998 -RRB-	17519
the reticulospinal tract	17519
Jordan	17545
1998	17553
we	17573
the reticulospinal tract	17587
significantly fewer fibers	17624
the caudal spinal cord than , for example , the vestibulospinal tract	17656
the caudal spinal cord	17656
example	17689
the vestibulospinal tract	17698
we	17725
fibers	17745
the reticulospinal tract	17757
their projection	17795
lesions -LRB- Ballermann and Fouad , 2006 -RRB-	17839
lesions	17839
Ballermann and Fouad , 2006	17848
Ballermann and Fouad	17848
2006	17870
a relatively small number of reticulospinal tract fibers	17883
a relatively small number	17883
reticulospinal tract fibers	17912
strong impact	17960
the activation of pattern generating networks	17977
the activation	17977
pattern generating networks	17995
locomotor movements	18046
recent studies	18076
lesioned descending tracts -LRB- i.e. , the CST -RRB-	18104
lesioned descending tracts	18104
i.e. , the CST	18132
i.e.	18132
the CST	18138
propriospinal interneurons	18164
Bareyre	18192
et al. , 2004 ; Vavrek et al. , 2006	18200
et al.	18200
2004 ; Vavrek et al.	18208
2004	18208
Vavrek et al.	18214
Vavrek	18214
et al.	18221
2006	18229
not only regenerated fibers	18249
functional recovery	18295
pathways	18334
the relatively large population of regenerated interneurons	18364
the relatively large population	18364
regenerated interneurons	18399
